Stay updated with breaking news from Argenx se adr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Argenx stock lost a third of its value as the Amsterdam biotech said a late-stage trial did not meet primary or secondary endpoints. The Phase 3 study was of. ....